Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Chamberlain

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
ILAR Journal|March 19, 2009
Gene therapy in large animal models of muscular dystrophyZejing Wang, Jeffrey S Chamberlain, Stephen J Tapscott, et al.
Experimental Gerontology|November 16, 2013
Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in DrosophilaOuarda Taghli-Lamallem, Krzysztof Jagla, Jeffrey S Chamberlain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2011
Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during agingDeWayne Townsend, Michael Daly, Jeffrey S Chamberlain, et al.
Methods in Enzymology|March 9, 2002
Generation and growth of gutted adenoviral vectorsDennis Hartigan-O'Connor, Catherine Barjot, Giovanni Salvatori, et al.
Human Gene Therapy|March 5, 2002
Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selectionDennis Hartigan-O'Connor, Catherine Barjot, Robert Crawford, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2005
Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codeliverySimone Abmayr, Paul Gregorevic, James M Allen, et al.
Frontiers in Microbiology|October 8, 2011
Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human TrialsZejing Wang, Stephen J Tapscott, Jeffrey S Chamberlain, et al.
Human Molecular Genetics|July 26, 2002
Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeableScott Q Harper, Robert W Crawford, Christiana DelloRusso, et al.
Blood|August 16, 2005
Donor origin of multipotent adult progenitor cells in radiation chimerasMorayma Reyes, Sheng Li, Jessica Foraker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 23, 2010
Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6Guy L Odom, Paul Gregorevic, James M Allen, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
ILAR Journal|March 19, 2009
Gene therapy in large animal models of muscular dystrophyZejing Wang, Jeffrey S Chamberlain, Stephen J Tapscott, et al.
Experimental Gerontology|November 16, 2013
Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in DrosophilaOuarda Taghli-Lamallem, Krzysztof Jagla, Jeffrey S Chamberlain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2011
Age-dependent dystrophin loss and genetic reconstitution establish a molecular link between dystrophin and heart performance during agingDeWayne Townsend, Michael Daly, Jeffrey S Chamberlain, et al.
Methods in Enzymology|March 9, 2002
Generation and growth of gutted adenoviral vectorsDennis Hartigan-O'Connor, Catherine Barjot, Giovanni Salvatori, et al.
Human Gene Therapy|March 5, 2002
Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selectionDennis Hartigan-O'Connor, Catherine Barjot, Robert Crawford, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 16, 2005
Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codeliverySimone Abmayr, Paul Gregorevic, James M Allen, et al.
Frontiers in Microbiology|October 8, 2011
Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human TrialsZejing Wang, Stephen J Tapscott, Jeffrey S Chamberlain, et al.
Human Molecular Genetics|July 26, 2002
Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeableScott Q Harper, Robert W Crawford, Christiana DelloRusso, et al.
Blood|August 16, 2005
Donor origin of multipotent adult progenitor cells in radiation chimerasMorayma Reyes, Sheng Li, Jessica Foraker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 23, 2010
Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6Guy L Odom, Paul Gregorevic, James M Allen, et al.
Pageof 17